Pfizer Inc. (NYSE:PFE)’s speaking payments fell 62 percent over the same period, from nearly $22 million to $8.3 million. Pfizer Inc. (NYSE:PFE) stock opened at $32.34 in last session, and closed at $32.69, while the day range of PFE stock is $32.34 – $32.74. The stock showed a positive weekly performance of 2.51%.
An executive with Bristol-Myers Squibb Co (NYSE:BMY) said Tuesday that the company is planning a phase-three trial of its drugs nivolumab and Yervoy to treat lung cancer. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $53.98, in last session and closed at $56.42, by gaining 5.48%. The 52 week range of BMY is $36.43 – $56.83. Company’s market capitalization is $93.11billion.
Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). Merck & Co., Inc. (NYSE:MRK) stock advanced 1.13% and finished the last session at $57.06. The EPS of the stock remained 1.48. Company’s market capitalization is $167.79billion.
Baxter International Inc. (BAX:US) filed a complaint Feb. 28 at the U.S. International Trade Commission in Washington, claiming Johnson & Johnson (NYSE:JNJ) hemostatic products used to control bleeding during surgery infringe five patents. Johnson & Johnson (NYSE:JNJ) stock opened the session at $92.47, and closed the session at $93.34. The 52 week range of the JNJ stock remained $76.73 – $95.99 and the day range was $92.25 – $93.46.
Leave a Reply